News
By Dennis Thompson HealthDay ReporterMONDAY, July 14, 2025 (HealthDay News) — Good news for women of a certain age: Hormone ...
The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the start.
Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.
A FAT jab user has revealed that after stopping the injections for eight weeks, she has now realised she is a “Mounjaro lifer ...
About one-third of Canadians have become obese — with more weight gain happening during the pandemic, according to a new ...
Cody Crone opened up about his dramatic transformation, revealing that he went from 209 lbs (95 kg) to 183.8 lbs (83 kg).
While we have commonly heard of common side effects of weight loss jabs such as nausea and constipation, there is a new concern that experts are highlighting and users are discussing across support ...
GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...
This year, drug companies have been living under a cloud of uncertainty created by the Trump administration. Threats of tough ...
Dr Chaey Leem is an obesity doctor, so he knows all about the challenges of losing weight. He joins us to answer listener's ...
Health and Human Services Secretary Robert F. Kennedy Jr. lambasted federal agencies he accused of being overly influenced by ...
EXCLUSIVE: Top doctor Dr Kim Boyd says its programmes are needed 'more than ever' despite the boom in weight loss drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results